Prisma Health-upstate
Clinical trials sponsored by Prisma Health-upstate, explained in plain language.
-
New drug combo tested for Tough-to-Treat rare cancers
Disease control TerminatedThis study tested a combination of two immunotherapy drugs, durvalumab and tremelimumab, for people with advanced rare solid tumors who had no other standard treatment options. The goal was to see if the drugs could shrink tumors and were safe for patients. The trial was designed…
Phase: PHASE2 • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Targeted drug trial seeks to control tumors driven by specific genetic flaw
Disease control TerminatedThis study tested whether the drug tazemetostat could help control advanced solid tumors that have a specific genetic change called an ARID1A mutation. The drug was given to adult patients whose cancer had progressed after standard treatments. The goal was to see if blocking a re…
Phase: PHASE2 • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC